Circular RNA (circRNA) is involved in the occurrence and development of various cancers. To this day, the expression and mechanism of circRNA in osteosarcoma (OS) remain unclear. We previously found that circ_0001060 was highly expressed in OS tumor tissues. In this work, we identified that high level expression of circ_0001060 was significantly associated with late clinical stage, larger tumor volume, higher frequency of metastasis, and poor prognosis in OS patients. Furthermore, we confirmed that silencing circ_0001060 inhibited the proliferation and migration of OS cell. Using bioinformatics analysis, we built three circRNA-miRNA-mRNA regulatory modules (circ_0001060-miR-203a-5p-TRIM21, circ_0001060-miR-208b-5p-MAP3K5, and circ_0001060-miR-203a-5p-PRKX), suggesting that these signaling axes may be involved in the inhibitory effect of circ_0001060 on OS. To sum up, circ_0001060 is a novel tumor biomarker for OS as well as a potential therapeutic target.
Get full access to this article
View all access options for this article.
References
1.
BeermannJ, PiccoliM, ViereckJ, et al.Non-coding RNAs in development and disease: Background, mechanisms, and therapeutic approaches. Physiol Rev, 2016; 96:1297–1325; doi: 10.1152/physrev.00041.2015
2.
BurnsJ, WildingC, JonesR, et al.Proteomic research in sarcomas—current status and future opportunities. Semin Cancer Biol, 2020; 61:56–70; doi: 10.1016/j.semcancer.2019.11.003
3.
ChenC, HuangZ, MoX, et al.The circular RNA 001971/miR-29c-3p axis modulates colorectal cancer growth, metastasis, and angiogenesis through VEGFA. J Exp Clin Cancer Res CR, 2020; 39:91; doi: 10.1186/s13046-020-01594-y
4.
ChenL. The expanding regulatory mechanisms and cellular functions of circular RNAs. Nat Rev Mol Cell Biol, 2020; 21:475–490; doi: 10.1038/s41580-020-0243-y
5.
CortiniM, AvnetS, BaldiniN. Mesenchymal stroma: Role in osteosarcoma progression. Cancer Lett, 2017; 405:90–99; doi: 10.1016/j.canlet.2017.07.024
6.
CuiX, WangJ, GuoZ, et al.Emerging function and potential diagnostic value of circular RNAs in cancer. Mol Cancer, 2018; 17:123; doi: 10.1186/s12943-018-0877-y
7.
FontemaggiG, TurcoC, EspositoG, et al.New molecular mechanisms and clinical impact of circRNAs in human cancer. Cancers (Basel) 2021;13; doi: 10.3390/cancers13133154
8.
FuL, WangH, LiaoY, et al.miR-208b modulating skeletal muscle development and energy homoeostasis through targeting distinct targets. RNA Biol, 2020; 17:743–754; doi: 10.1080/15476286.2020.1728102
9.
FujimotoM, KamiyamaM, FuseK, et al.ASK1 suppresses NK cell-mediated intravascular tumor cell clearance in lung metastasis. Cancer Sci, 2021; 112:1633–1643; doi: 10.1111/cas.14842
GlažarP, PapavasileiouP, RajewskyN. circBase: A database for circular RNAs. RNA (New York, NY), 2014; 20:1666–1670; doi: 10.1261/rna.043687.113
12.
GorlickR, JanewayK, LessnickS, et al.Children's Oncology Group's 2013 blueprint for research: Bone tumors. Pediatr Blood Cancer, 2013; 60:1009–1015; doi: 10.1002/pbc.24429
13.
GubbiottiM, BuraschiS, KapoorA, et al.Proteoglycan signaling in tumor angiogenesis and endothelial cell autophagy. Semin Cancer Biol, 2020; 62:1–8; doi: 10.1016/j.semcancer.2019.05.003
14.
HarrisonS, WongV, OkanoueT, et al.Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials. J Hepatol, 2020; 73:26–39; doi: 10.1016/j.jhep.2020.02.027
15.
HuangS, LiQ, AlbertsI, et al.PRKX, a novel cAMP-dependent protein kinase member, plays an important role in development. J Cell Biochem, 2016; 117:566–573; doi: 10.1002/jcb.25304
16.
IsakoffM, BielackS, MeltzerP, et al.Osteosarcoma: Current treatment and a collaborative pathway to success. J Clin Oncol: Official journal of the American Society of Clinical Oncology, 2015; 33:3029–3035; doi: 10.1200/jco.2014.59.4895
17.
KozomaraA, BirgaoanuM, Griffiths-JonesS. miRBase: From microRNA sequences to function. Nucleic Acids Res, 2019; 47:D155–D162; doi: 10.1093/nar/gky1141
18.
KristensenL, AndersenM, StagstedL, et al.The biogenesis, biology and characterization of circular RNAs. Nat Rev Genet, 2019; 20:675–691; doi: 10.1038/s41576-019-0158-7
19.
KristensenL, JakobsenT, HagerH, et al.The emerging roles of circRNAs in cancer and oncology. Nat Rev Clin Oncol, 2022; 19:188–206; doi: 10.1038/s41571-021-00585-y
20.
LanT, HuY, HuF, et al.Hepatocyte glutathione S-transferase mu 2 prevents non-alcoholic steatohepatitis by suppressing ASK1 signaling. J Hepatol, 2022; 76:407–419; doi: 10.1016/j.jhep.2021.09.040
LiuG, HuangK, JieZ, et al.CircFAT1 sponges miR-375 to promote the expression of Yes-associated protein 1 in osteosarcoma cells. Mol Cancer, 2018; 17:170; doi: 10.1186/s12943-018-0917-7
23.
LiuS, ShapiroJ, SaloustrosE, et al.Bone abnormalities in mice with protein kinase A (PKA) defects reveal a role of cyclic AMP signaling in bone stromal cell-dependent tumor development. Horm Metab Res, 2016; 48:714–725; doi: 10.1055/s-0042-117111
24.
LiuW, ZhangJ, ZouC, et al.Microarray expression profile and functional analysis of circular RNAs in osteosarcoma. Cell Physiol Biochem: International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology, 2017; 43:969–985; doi: 10.1159/000481650
25.
LiuW, ZhengL, ZhangR, et al.Circ-ZEB1 promotes PIK3CA expression by silencing miR-199a-3p and affects the proliferation and apoptosis of hepatocellular carcinoma. Mol Cancer, 2022; 21:72; doi: 10.1186/s12943-022-01529-5
26.
MaC, WangX, YangF, et al.Circular RNA hsa_circ_0004872 inhibits gastric cancer progression via the miR-224/Smad4/ADAR1 successive regulatory circuit. Mol Cancer, 2020; 19:157; doi: 10.1186/s12943-020-01268-5
27.
MeltzerP, HelmanL. New horizons in the treatment of osteosarcoma. N Engl J Med, 2021; 385:2066–2076; doi: 10.1056/NEJMra2103423
28.
MemczakS, JensM, ElefsiniotiA, et al.Circular RNAs are a large class of animal RNAs with regulatory potency. Nature, 2013; 495:333–338; doi: 10.1038/nature11928
29.
MengS, ZhouH, FengZ, et al.CircRNA: Functions and properties of a novel potential biomarker for cancer. Mol Cancer, 2017; 16:94; doi: 10.1186/s12943-017-0663-2
30.
NooneA, CroninK, AltekruseS, et al.Cancer incidence and survival trends by subtype using data from the surveillance epidemiology and end results program, 1992–2013. Cancer Epidemiol Biomarkers Prev: A publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2017; 26:632–641; doi: 10.1158/1055-9965.Epi-16-0520
31.
PiweckaM, GlažarP, Hernandez-MirandaL, et al.Loss of a mammalian circular RNA locus causes miRNA deregulation and affects brain function. Science (New York, NY), 2017;357; doi: 10.1126/science.aam8526
32.
QiuM, XiaW, ChenR, et al.The circular RNA circPRKCI promotes tumor growth in lung adenocarcinoma. Cancer Res, 2018; 78:2839–2851; doi: 10.1158/0008-5472.Can-17-2808
33.
SchulteC, BarwariT, JoshiA, et al.Comparative analysis of circulating noncoding RNAs versus protein biomarkers in the detection of myocardial injury. Circ Res, 2019; 125:328–340; doi: 10.1161/circresaha.119.314937
34.
SzklarczykD, GableA, LyonD, et al.STRING v11: Protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res, 2019; 47:D607–D613; doi: 10.1093/nar/gky1131
35.
TuC, HeJ, QiL, et al.Emerging landscape of circular RNAs as biomarkers and pivotal regulators in osteosarcoma. J Cell Physiol, 2020; 235:9037–9058; doi: 10.1002/jcp.29754
36.
WhelanJ, DavisL. Osteosarcoma, chondrosarcoma, and chordoma. J Clin Oncol: Official journal of the American Society of Clinical Oncology, 2018; 36:188–193; doi: 10.1200/jco.2017.75.1743
37.
WiwegerM, AvramutC, de AndreaC, et al.Cartilage ultrastructure in proteoglycan-deficient zebrafish mutants brings to light new candidate genes for human skeletal disorders. J Pathol, 2011; 223:531–542; doi: 10.1002/path.2824
38.
WuY, XieZ, ChenJ, et al.Circular RNA circTADA2A promotes osteosarcoma progression and metastasis by sponging miR-203a-3p and regulating CREB3 expression. Mol Cancer, 2019; 18:73; doi: 10.1186/s12943-019-1007-1
39.
XiY, FowdurM, LiuY, et al.Differential expression and bioinformatics analysis of circRNA in osteosarcoma. Biosci Rep, 2019; 39; doi: 10.1042/bsr20181514
40.
XieF, LiY, WangM, et al.Circular RNA BCRC-3 suppresses bladder cancer proliferation through miR-182-5p/p27 axis. Mol Cancer, 2018; 17:144; doi: 10.1186/s12943-018-0892-z
41.
YaoC, WuS, LiD, et al.Co-administration phenoxodiol with doxorubicin synergistically inhibit the activity of sphingosine kinase-1 (SphK1), a potential oncogene of osteosarcoma, to suppress osteosarcoma cell growth both in vivo and in vitro. Mol Oncol, 2012; 6:392–404; doi: 10.1016/j.molonc.2012.04.002
42.
YuY, LvD, WangC, et al.Hsa_circ_0003258 promotes prostate cancer metastasis by complexing with IGF2BP3 and sponging miR-653-5p. Mol Cancer, 2022; 21:12; doi: 10.1186/s12943-021-01480-x
43.
ZhangH, ZengQ, WuB, et al.TRIM21-regulated Annexin A2 plasma membrane trafficking facilitates osteosarcoma cell differentiation through the TFEB-mediated autophagy. Cell Death Dis, 2021; 12:21; doi: 10.1038/s41419-020-03364-2
44.
ZhengS, HuC, LinH, et al.circCUL2 induces an inflammatory CAF phenotype in pancreatic ductal adenocarcinoma via the activation of the MyD88-dependent NF-κB signaling pathway. J Exp Clin Cancer Res CR, 2022; 41:71; doi: 10.1186/s13046-021-02237-6
45.
ZhongY, DuY, YangX, et al.Circular RNAs function as ceRNAs to regulate and control human cancer progression. Mol Cancer, 2018; 17:79; doi: 10.1186/s12943-018-0827-8
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
